Characterizing the role of ER-shaping proteins during RNA virus infection

表征 ER 塑造蛋白在 RNA 病毒感染过程中的作用

基本信息

项目摘要

PROJECT SUMMARY All positive-stranded RNA viruses manipulate host cell membranes for the biogenesis of their replication organelles. These structures are thought to concentrate cellular and viral factors that are required for replication and create an environment that helps to protect the virus from innate immune sensors. Enteroviruses, such as coxsackievirus B3 (CVB), and flaviviruses, such as dengue virus (DENV), represent two families of positive-stranded RNA viruses that induce the formation of distinct classes of replication organelles. Enterovirus infection results in the formation of cytoplasmic single- and double-membrane vesicles that contain endoplasmic reticulum (ER) and autophagic markers. Enteroviral replication proteins are anchored on the outer membrane leaflets of these vesicles, where they coordinate viral genome replication. In addition to infecting humans, most flaviviruses must efficiently replicate in insect vectors, such as mosquitoes and ticks. Flaviviruses induce the formation of vesicular invaginations of the ER that contain a small opening to the cytoplasm. Genome replication is mediated within these structures by the viral nonstructural proteins, which are concentrated in the vesicles. Despite the evidence that exists for the involvement of the ER in establishing these distinct replication organelles there is a lack of knowledge regarding the role of ER-associated membrane shaping regulators during enterovirus and flavivirus replication. The ER is a large, dynamic organelle that exists as perinuclear sheets and a cytoplasmic network of tubules, which encompass a contiguous lumen. The dynamics and unique shape of this organelle are regulated by the expression of several classes of ER-shaping proteins, many of which are conserved from yeast to humans. My preliminary results indicate that several of these proteins act as regulators of CVB and DENV infection. Thus, we hypothesize that enteroviruses and flaviviruses target specific ER-shaping proteins to facilitate their replication. The first set of proposed studies are designed to delineate the mechanisms by which reticulons, ER-shaping proteins that promote membrane curvature, regulate infection by CVB and DENV. Furthermore, we will determine the role of the insect reticulon homolog during DENV infection of insect cells. The second set of proposed studies will characterize the role of FAM134B during DENV infection. FAM134B is a recently identified ER-shaping protein that regulates autophagy-mediated degradation of the ER (ER-phagy). Results from these studies will provide details on novel host-pathogen interactions that mediate replication of two RNA viruses, which represent a significant public health burden. Information derived from our results will provide significant insight into the biology of these viruses that can be utilized in the development of antivirals to combat disease. Furthermore, our results will also help to define the specific role of ER-shaping proteins in regulating the shape and dynamics of the ER.
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Nicholas J Lennemann其他文献

Nicholas J Lennemann的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Nicholas J Lennemann', 18)}}的其他基金

Mechanisms of astrovirus infection
星状病毒感染机制
  • 批准号:
    10712313
  • 财政年份:
    2023
  • 资助金额:
    $ 5.61万
  • 项目类别:
Regulation of positive-stranded RNA virus infection by host factors of the endomembrane system
内膜系统宿主因子对正链RNA病毒感染的调节
  • 批准号:
    10204867
  • 财政年份:
    2020
  • 资助金额:
    $ 5.61万
  • 项目类别:
Regulation of positive-stranded RNA virus infection by host factors of the endomembrane system
内膜系统宿主因子对正链RNA病毒感染的调节
  • 批准号:
    9720399
  • 财政年份:
    2020
  • 资助金额:
    $ 5.61万
  • 项目类别:

相似海外基金

Development of a new generation of antiviral agents that are effective against drug-resistant viruses and prevent serious illness and sequelae.
开发新一代抗病毒药物,可有效对抗耐药病毒并预防严重疾病和后遗症。
  • 批准号:
    23K18186
  • 财政年份:
    2023
  • 资助金额:
    $ 5.61万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents
一个多功能的基于结构的治疗平台,用于开发基于 VHH 的抗毒素和抗病毒药物
  • 批准号:
    10560883
  • 财政年份:
    2023
  • 资助金额:
    $ 5.61万
  • 项目类别:
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
  • 批准号:
    10730692
  • 财政年份:
    2021
  • 资助金额:
    $ 5.61万
  • 项目类别:
Design and synthesis of nucleosides to develop antiviral agents and oligonucleotide therapeutics
设计和合成核苷以开发抗病毒药物和寡核苷酸疗法
  • 批准号:
    21K06459
  • 财政年份:
    2021
  • 资助金额:
    $ 5.61万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
  • 批准号:
    10189880
  • 财政年份:
    2021
  • 资助金额:
    $ 5.61万
  • 项目类别:
Computer-aided identification and synthesis of novel broad-spectrum antiviral agents
新型广谱抗病毒药物的计算机辅助鉴定和合成
  • 批准号:
    2404261
  • 财政年份:
    2020
  • 资助金额:
    $ 5.61万
  • 项目类别:
    Studentship
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
  • 批准号:
    10222540
  • 财政年份:
    2020
  • 资助金额:
    $ 5.61万
  • 项目类别:
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
  • 批准号:
    10669717
  • 财政年份:
    2020
  • 资助金额:
    $ 5.61万
  • 项目类别:
Association between sedentary lifestyle and liver cancer development in hepatitis C patients treated with direct-acting antiviral agents
接受直接抗病毒药物治疗的丙型肝炎患者久坐的生活方式与肝癌发展之间的关系
  • 批准号:
    20K10713
  • 财政年份:
    2020
  • 资助金额:
    $ 5.61万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
  • 批准号:
    10174522
  • 财政年份:
    2020
  • 资助金额:
    $ 5.61万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了